RDY · Dr Reddys Laboratories Ltd · Documents

$14.15 +0.40 (+2.91%) At close · Oct 28 Q2 2026 earnings call transcript

Market Cap

$11.73B

833.07M

Volume · Oct 28 4.47M Avg daily vol (3M) 2.92M

The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.

Type	AI summary	Filing Date	Period
6-K	—	2021-01-08	—
6-K	—	2020-12-29	—
6-K	—	2020-12-28	—
6-K	—	2020-12-22	2020-12-21
6-K	—	2020-12-09	—
6-K	—	2020-12-08	—
6-K	—	2020-12-08	2020-12-01
6-K	—	2020-11-30	2020-11-28
6-K	—	2020-11-19	—
6-K	—	2020-11-13	2020-11-12
6-K	—	2020-10-30	2020-10-29
6-K	—	2020-10-29	—
6-K	—	2020-10-29	—
6-K	—	2020-10-28	—
6-K	—	2020-10-28	—
6-K	—	2020-10-22	—
6-K	—	2020-10-20	—
6-K	—	2020-10-19	2020-10-17
6-K	—	2020-10-13	2020-10-12
6-K	—	2020-10-05	—
6-K	—	2020-10-05	—
6-K	—	2020-10-01	—
6-K	—	2020-09-28	2020-09-26
6-K	—	2020-09-28	2020-09-27
6-K	—	2020-09-25	—
6-K	—	2020-09-23	—
6-K	—	2020-09-17	—
6-K	—	2020-09-16	—
6-K	—	2020-09-09	—
6-K	—	2020-09-08	2020-09-07
6-K	—	2020-09-03	—
6-K	—	2020-08-28	—
6-K	—	2020-08-27	—
6-K	—	2020-08-19	—
6-K	—	2020-08-17	—
6-K	—	2020-08-11	—
6-K	—	2020-08-03	2020-07-30
6-K	—	2020-07-31	2020-07-30
6-K	—	2020-07-29	—
6-K	—	2020-07-29	—
6-K	—	2020-07-27	—
6-K	—	2020-07-20	—
6-K	—	2020-07-14	—
6-K	—	2020-07-08	2020-07-07
6-K	—	2020-07-06	—
6-K	—	2020-07-01	—
6-K	—	2020-06-29	2020-06-27
6-K	—	2020-06-25	—
6-K	—	2020-06-23	—
6-K	—	2020-06-19	—

Showing 651–700 of 745 filings

Key facts CIK 1135951 CUSIP 256135203 13F (30d) 59 filings 54 filers Visit website Investor relations